drugset / Trial / NCT00126906

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi

NCT00126906 ↗

RandomizedParallel-groupOpen-labelEct

Summary

In Malawi, the standard of care to prevent malaria during pregnancy at the time of the study was a two dose sulfadoxine-pyrimethamine intermittent protective treatment (SP IPT) regimen administered in the second and third trimester of pregnancy. In this investigation, this two dose strategy was compared to a monthly SP regimen. The objective for the study was to determine the efficacy of the different regimens for HIV positive and HIV negative women in the prevention of placental malaria.

Timeline

Start
2002-10
Primary completion
—
Completion
2005-03

Outcome

Met primary endpoint

paper In HIV-positive pregnant women, monthly SP IPTp is more efficacious than a 2-dose regimen in preventing placental malaria. PMID 16826475 ↗

paper Of HIV-positive women, 7.8% who received monthly SP had placental malaria, compared with 21.5% of those who received 2-dose SP PMID 16826475 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject sulfadoxine-pyrimethamine Unknown — —